Target intelligence / Profile preview

MicroRNA-155 (miR-155)

Target
miR-155
Molecular classification
MicroRNA, Non-coding RNA, Epigenetic regulator, Other
01

Overview

MicroRNA-155 is a small, non-coding RNA molecule (microRNA) highly conserved among vertebrates, encoded by the MIR155 host gene (MIR155HG), originally called the B-cell Integration Cluster (BIC)[1][5][8]. It is a master regulator of gene expression at the post-transcriptional level, primarily by binding to complementary sequences in target messenger RNAs to inhibit their expression or induce degradation. MiR-155 plays essential roles in immune system development and function, controlling the differentiation, proliferation, and activation of diverse immune cells such as B cells, T cells (including Th1, Th2, Th17, and Tregs), macrophages, dendritic cells, and invariant natural killer T cells[2][3][4][6]. Its expression is dynamically regulated in response to inflammatory cues, cytokines, or pathogen exposure[4][5][8]. Pathologically, miR-155 is frequently overexpressed in cancers (notably lymphoid malignancies), where it drives tumorigenesis and supports malignant cell survival[7][9]. It is also involved in autoimmune and inflammatory diseases, cardiovascular pathologies, and infections, making it a prominent therapeutic target for drug development[5][7]. Experimental drugs targeting miR-155 mostly involve antisense technologies delivered via nanoparticles, aiming to knock down excess miR-155 and restore normal cellular function in disease, though clinical translation remains challenging due to safety and specificity concerns[7]. MiR-155 is commonly measured as a biomarker for disease diagnosis and monitoring, especially in cancer and autoimmune conditions, reflecting its pathological importance. However, therapeutic targeting must balance efficacy with the risk of impairing essential immune functions and hematopoiesis, a major challenge for future clinical applications[5][7].

Other names
MIR155MIR155HGmiR-155-5pBIC (B-cell Integration Cluster)miRNA-155
02

Mechanism of action

Inhibition of miR-155 function by antisense oligonucleotides (anti-miR-155) Suppression of pathological overexpression, restoring normal gene regulation[7]

03

Biological functions

Regulation of immune responseCell proliferationApoptosisCell differentiationHematopoiesisInflammatory signalingEpigenetic gene regulationHomeostasisB-cell maturation and antibody production
04

Disease associations

Cancer (especially lymphoma, leukemia, breast cancer, others)InflammationCardiovascular diseasesAutoimmune diseasesInfectionPulmonary disordersOther
05

Safety considerations

Off-target gene regulation due to microRNA network complexityPotential for immune suppression or dysregulationRisk of affecting normal hematopoiesis and differentiationUnintended effects on non-target tissuesLimited tissue specificity of systemic anti-miRNA therapies
06

Interacting drugs

Antisense peptide nucleic acids (experimental)[7]

3 more in the full profile.

07

Biomarkers

miR-155 expression level (in tissue or circulating blood) for diagnosis, prognosis, or monitoring therapeutic efficacy in cancers, chronic inflammation, and autoimmune disorders[5]miR-155-5p concentration

Beyond the preview

Go deeper on MicroRNA-155 (miR-155).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-155 (miR-155).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call